Galenica announces plans for IPO of Galenica Santé on SIX Swiss Exchange

Galenica expects to sell the majority of its Galenica Santé shares in an IPO on SIX Swiss Exchange. The objective is to fully divest Galenica Santé over the medium term in order to complete the separation of the two businesses. Assuming stable market conditions, Galenica anticipates that the listing can be completed during the second quarter of 2017.
At the next Annual General Meeting of Galenica Ltd., the name of the Galenica Group is to be changed into Vifor Pharma Group so that Galenica Santé can trade under the Galenica name.